# Temozolomide in Treating Patients With Low-Grade Glioma

> **NCT00313729** · PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 120 (actual)

## Conditions studied

- CNS Tumor, Adult

## Interventions

- **DRUG:** temozolomide

## Key facts

- **NCT ID:** NCT00313729
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-05
- **Primary completion:** 2014-09-25
- **Final completion:** 2017-06-12
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00313729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00313729, "Temozolomide in Treating Patients With Low-Grade Glioma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00313729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*